Total Payments
$53,899
2024 Payments
$677.40
Companies
18
Transactions
197
Medicare Patients
489
Medicare Billing
$132,227
Payment Breakdown by Category
Other$37,524 (69.6%)
Travel$10,150 (18.8%)
Food & Beverage$6,226 (11.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $32,524 | 15 | 60.3% |
| Travel and Lodging | $10,150 | 26 | 18.8% |
| Food and Beverage | $6,226 | 154 | 11.6% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $5,000 | 2 | 9.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sunovion Pharmaceuticals Inc. | $33,938 | 82 | $0 (2019) |
| LivaNova USA, Inc. | $9,802 | 42 | $0 (2023) |
| Supernus Pharmaceuticals, Inc. | $7,951 | 19 | $0 (2021) |
| CATALYST PHARMACEUTICALS, INC. | $624.74 | 5 | $0 (2024) |
| UCB, Inc. | $480.10 | 12 | $0 (2024) |
| Lundbeck LLC | $242.58 | 13 | $0 (2017) |
| Cyberonics, Inc. | $217.82 | 6 | $0 (2017) |
| JAZZ PHARMACEUTICALS INC. | $178.50 | 2 | $0 (2024) |
| GENZYME CORPORATION | $123.93 | 6 | $0 (2018) |
| Zogenix Inc. | $102.00 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $677.40 | 7 | CATALYST PHARMACEUTICALS, INC. ($281.91) |
| 2023 | $1,188 | 5 | LivaNova USA, Inc. ($844.90) |
| 2022 | $78.77 | 2 | LivaNova USA, Inc. ($78.77) |
| 2021 | $3,942 | 11 | Supernus Pharmaceuticals, Inc. ($3,772) |
| 2020 | $62.33 | 1 | LivaNova USA, Inc. ($62.33) |
| 2019 | $4,602 | 18 | Supernus Pharmaceuticals, Inc. ($4,107) |
| 2018 | $16,586 | 43 | Sunovion Pharmaceuticals Inc. ($8,395) |
| 2017 | $26,763 | 110 | Sunovion Pharmaceuticals Inc. ($25,386) |
All Payment Transactions
197 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/08/2024 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $199.67 | General |
| 12/07/2024 | CATALYST PHARMACEUTICALS, INC. | FYCOMPA (Drug) | Food and Beverage | Cash or cash equivalent | $149.05 | General |
| Category: NEUROLOGY | ||||||
| 12/07/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $136.39 | General |
| Category: NEUROLOGY | ||||||
| 12/07/2024 | CATALYST PHARMACEUTICALS, INC. | FYCOMPA (Drug) | Food and Beverage | Cash or cash equivalent | $25.76 | General |
| Category: NEUROLOGY | ||||||
| 10/03/2024 | CATALYST PHARMACEUTICALS, INC. | FYCOMPA (Drug) | Food and Beverage | Cash or cash equivalent | $107.10 | General |
| Category: NEUROLOGY | ||||||
| 07/01/2024 | JAZZ PHARMACEUTICALS INC. | — | Food and Beverage | In-kind items and services | $42.11 | General |
| 01/18/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $17.32 | General |
| 12/03/2023 | LivaNova USA, Inc. | VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) | Food and Beverage | In-kind items and services | $93.28 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/02/2023 | Catalyst Pharmaceuticals, Inc. | FYCOMPA (Drug) | Food and Beverage | Cash or cash equivalent | $205.74 | General |
| Category: NEUROLOGY | ||||||
| 12/01/2023 | Catalyst Pharmaceuticals, Inc. | FYCOMPA (Drug) | Food and Beverage | Cash or cash equivalent | $137.09 | General |
| Category: NEUROLOGY | ||||||
| 07/12/2023 | LivaNova USA, Inc. | VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) | Food and Beverage | In-kind items and services | $9.12 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/24/2023 | LivaNova USA, Inc. | VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $742.50 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/17/2022 | LivaNova USA, Inc. | VNS Therapy SenTiva Model 1000 Generator (Device) | Food and Beverage | In-kind items and services | $12.70 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/05/2022 | LivaNova USA, Inc. | VNS Therapy SenTiva Model 1000 Generator (Device) | Food and Beverage | In-kind items and services | $66.07 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/04/2021 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $50.00 | General |
| 12/04/2021 | UCB, Inc. | — | Travel and Lodging | In-kind items and services | $18.37 | General |
| 09/17/2021 | Supernus Pharmaceuticals, Inc. | OXTELLAR XR (Drug) | Food and Beverage | Cash or cash equivalent | $96.08 | General |
| Category: AED | ||||||
| 09/17/2021 | Supernus Pharmaceuticals, Inc. | OXTELLAR XR (Drug) | Food and Beverage | Cash or cash equivalent | $75.01 | General |
| Category: AED | ||||||
| 09/17/2021 | Supernus Pharmaceuticals, Inc. | OXTELLAR XR (Drug) | Food and Beverage | Cash or cash equivalent | $60.00 | General |
| Category: AED | ||||||
| 09/16/2021 | Supernus Pharmaceuticals, Inc. | OXTELLAR XR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,500.00 | General |
| Category: AED | ||||||
| 09/16/2021 | Supernus Pharmaceuticals, Inc. | OXTELLAR XR (Drug) | Travel and Lodging | Cash or cash equivalent | $463.30 | General |
| Category: AED | ||||||
| 09/16/2021 | Supernus Pharmaceuticals, Inc. | OXTELLAR XR (Drug) | Travel and Lodging | Cash or cash equivalent | $309.22 | General |
| Category: AED | ||||||
| 09/16/2021 | Supernus Pharmaceuticals, Inc. | OXTELLAR XR (Drug) | Travel and Lodging | In-kind items and services | $143.40 | General |
| Category: AED | ||||||
| 09/16/2021 | Supernus Pharmaceuticals, Inc. | OXTELLAR XR (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: AED | ||||||
| 04/15/2021 | Zogenix Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $102.00 | General |
| Category: Treatment of seizures | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 196 | 264 | $107,190 | $47,844 |
| 2022 | 3 | 91 | 211 | $64,045 | $32,506 |
| 2021 | 3 | 119 | 218 | $75,445 | $38,522 |
| 2020 | 4 | 83 | 124 | $33,035 | $13,355 |
Total Patients
489
Total Services
817
Medicare Billing
$132,227
Procedure Codes
13
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2023 | 69 | 69 | $48,300 | $22,799 | 47.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 70 | 138 | $33,810 | $16,877 | 49.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 57 | 57 | $25,080 | $8,168 | 32.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 49 | 169 | $41,405 | $22,329 | 53.9% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2022 | 16 | 16 | $11,200 | $5,825 | 52.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 26 | 26 | $11,440 | $4,352 | 38.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 54 | 153 | $37,485 | $20,428 | 54.5% |
| 95819 | Measurement and recording of brain wave (eeg) activity, awake and asleep | Office | 2021 | 36 | 36 | $25,200 | $12,983 | 51.5% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 29 | 29 | $12,760 | $5,111 | 40.1% |
| 95813 | Measurement of brain wave activity (eeg) extended monitoring, 61-119 minutes | Office | 2020 | 12 | 12 | $9,600 | $3,862 | 40.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 26 | 61 | $7,625 | $3,531 | 46.3% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 28 | 34 | $8,330 | $3,350 | 40.2% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 17 | 17 | $7,480 | $2,612 | 34.9% |
About Dr. Thomas Swanson, MD
Dr. Thomas Swanson, MD is a Neurology healthcare provider based in Missoula, Montana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/16/2005. The National Provider Identifier (NPI) number assigned to this provider is 1376535575.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Swanson, MD has received a total of $53,899 in payments from pharmaceutical and medical device companies, with $677.40 received in 2024. These payments were reported across 197 transactions from 18 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($32,524).
As a Medicare-enrolled provider, Swanson has provided services to 489 Medicare beneficiaries, totaling 817 services with total Medicare billing of $132,227. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Neurology
- Location Missoula, MT
- Active Since 08/16/2005
- Last Updated 07/27/2023
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1376535575
Products in Payments
- APTIOM (Drug) $33,938
- VNS Therapy (Device) $9,096
- OXTELLAR XR (Drug) $7,922
- VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) $844.90
- FYCOMPA (Drug) $624.74
- ONFI (Drug) $230.03
- Briviact (Drug) $163.56
- EPIDIOLEX (Drug) $136.39
- Fintepla (Drug) $102.00
- VNS Therapy SenTiva Model 1000 Generator (Device) $78.77
- Epidiolex (Drug) $78.67
- LEMTRADA (Drug) $73.18
- Fycompa (Drug) $59.26
- AUBAGIO (Drug) $50.75
- AMPYRA (Drug) $31.51
- TROKENDI XR (Drug) $28.76
- Zinbryta (Biological) $14.06
- NUPLAZID (Drug) $13.92
- KEVEYIS (Drug) $12.58
- NORTHERA (Drug) $12.55
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Missoula
Dr. John Schaeffer, D.o, D.O
Neurology — Payments: $3,955
Neurology $3,955
Sarah Koch, Md, MD
Neurology — Payments: $2,087
Neurology $2,087
Mackenzie Westphal, Np, NP
Neurology — Payments: $1,678
Neurology $1,678
Dr. Kyle Smith, D.o, D.O
Neurology — Payments: $1,065
Neurology $1,065
Lennard Wilson, M.d, M.D
Neurology
Neurology
Stephen Johnson, M.d, M.D
Neurology
Neurology